E2 ModerateModerate confidencePEM not requiredCross-SectionalPeer-reviewedReviewed
Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis.
Gottschalk, Michaela, Kümpfel, Tania, Flachenecker, Peter et al. · Archives of neurology · 2005 · DOI
Quick Summary
This study looked at fatigue in multiple sclerosis (MS) patients and examined whether their stress hormone system (HPA axis) might be involved. Researchers tested 31 MS patients using three different fatigue questionnaires and a special hormone test. They found that MS patients with severe fatigue had higher levels of a stress hormone called ACTH compared to MS patients without fatigue.
Why It Matters
This study is relevant to ME/CFS research because it identifies a potential neuroendocrine mechanism for fatigue in another chronic disease, providing a comparative framework. The finding of HPA axis hyperactivity in MS fatigue (contrasting with CFS hypoactivity) highlights that fatigue in different conditions may have distinct biological underpinnings, which could inform targeted therapeutic approaches for ME/CFS.
Observed Findings
- FSS and MFIS fatigue scores were significantly correlated in MS patients
- MS patients with fatigue had significantly elevated ACTH levels on combined Dex-CRH testing compared to non-fatigued MS patients
- HPA axis showed hyperactivity in fatigued MS patients, opposite to the hyporeactivity reported in chronic fatigue syndrome
- Proinflammatory cytokines are elevated in MS and may mediate both HPA axis changes and fatigue symptoms
Inferred Conclusions
- HPA axis dysregulation may contribute to fatigue in MS through enhanced ACTH responsiveness rather than suppression
- The HPA axis profile in MS fatigue differs fundamentally from that in CFS, suggesting distinct neuroendocrine mechanisms
- Inflammatory cytokines may serve as the common pathophysiologic link between HPA axis alterations and fatigue in MS
Remaining Questions
- Does elevated ACTH directly cause fatigue in MS, or is it a secondary marker of another underlying process?
- How do inflammatory cytokine levels correlate specifically with both ACTH elevation and fatigue severity in MS?
- Why do different chronic fatigue conditions (MS vs CFS) show opposite HPA axis patterns, and what determines which pattern emerges?
What This Study Does Not Prove
This study does not establish causation—elevated ACTH may be a consequence rather than a cause of fatigue. The study is in MS patients, not ME/CFS patients, so findings may not directly apply to ME/CFS populations. The small sample size and lack of healthy control group limit generalizability of the HPA axis findings.
Tags
Symptom:Fatigue
Biomarker:CytokinesBlood Biomarker
Method Flag:No ControlsSmall SampleExploratory OnlyWeak Case Definition
Metadata
- DOI
- 10.1001/archneur.62.2.277
- PMID
- 15710856
- Review status
- Editor reviewed
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.